Perspective Therapeutics Stock Technical Analysis
| CATX Stock | 3.47 0.47 15.67% |
As of the 25th of November, Perspective Therapeutics holds the Variance of 61.4, risk adjusted performance of (0.17), and Coefficient Of Variation of (439.19). Perspective Therapeutics technical analysis gives you tools to exploit past prices in attempt to determine a pattern that determines the direction of the company's future prices.
Perspective Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Perspective, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to PerspectivePerspective |
Perspective Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 1.2 | Strong Buy | 10 | Odds |
Most Perspective analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Perspective stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Perspective Therapeutics, talking to its executives and customers, or listening to Perspective conference calls.
Perspective Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Perspective Therapeutics Technical Analysis
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Perspective Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Perspective Therapeutics Trend Analysis
Use this graph to draw trend lines for Perspective Therapeutics. You can use it to identify possible trend reversals for Perspective Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Perspective Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Perspective Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Perspective Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.13 , which may suggest that Perspective Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 659.4, which is the sum of squared deviations for the predicted Perspective Therapeutics price change compared to its average price change.About Perspective Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Perspective Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Perspective Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Perspective Therapeutics price pattern first instead of the macroeconomic environment surrounding Perspective Therapeutics. By analyzing Perspective Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Perspective Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Perspective Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 54.37 | 70.03 | 63.03 | 45.97 | PTB Ratio | 7.16 | 6.42 | 5.78 | 5.49 |
Perspective Therapeutics November 25, 2024 Technical Indicators
Most technical analysis of Perspective help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Perspective from various momentum indicators to cycle indicators. When you analyze Perspective charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.17) | |||
| Market Risk Adjusted Performance | (6.20) | |||
| Mean Deviation | 4.47 | |||
| Coefficient Of Variation | (439.19) | |||
| Standard Deviation | 7.84 | |||
| Variance | 61.4 | |||
| Information Ratio | (0.24) | |||
| Jensen Alpha | (1.83) | |||
| Total Risk Alpha | (3.03) | |||
| Treynor Ratio | (6.21) | |||
| Maximum Drawdown | 57.58 | |||
| Value At Risk | (11.66) | |||
| Potential Upside | 4.59 | |||
| Skewness | (3.94) | |||
| Kurtosis | 24.65 |
Additional Tools for Perspective Stock Analysis
When running Perspective Therapeutics' price analysis, check to measure Perspective Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Perspective Therapeutics is operating at the current time. Most of Perspective Therapeutics' value examination focuses on studying past and present price action to predict the probability of Perspective Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Perspective Therapeutics' price. Additionally, you may evaluate how the addition of Perspective Therapeutics to your portfolios can decrease your overall portfolio volatility.